Chronic Disease Management which was also known as enhanced primary care earlier is the
ongoing care and support which help in managing the health care of patient suffering with
chronic disease such as asthma, cancer, diabetes, cardiovascular diseases, stroke, etc. It
also require visits and support from the family physician, other primary care provider,
community-based programs or referrals to specialist programs and services.
Long-term care centers and rehabilitation centers generally provide chronic disease
management services. In chronic care management services, patient are aware of more
reliable treatment options. Increase prevalence of chronic disease worldwide is the major
factor of market growth for chronic disease management globally.
The Global Chronic Disease Management Market is expected to grow at a CAGR of 17.5%
during the forecast period 2017-2023.
According to National Cancer Institute, in 2016, U.S. diagnosed around 1,685,210 new
cases of cancer, and in 2014, around 15,780 children and adolescents ages 0-19 were
diagnosed with cancer and 1,960 died of the disease. Rapidly increasing patient population
leads to the chronic management market.
There are various causes which increase the chronic disease, such as rising aging
population, unhealthy diet, low physical activities, etc. According to a research, smoking
increases the possibility of diabetes; more than 60% of the global population smokes, this
has increased the risk of diabetes and contributed to the growth of the market. According to
the International Diabetes Federation in 2016, it was estimated that 420 million adult
population is suffering from diabetes which is increasing at the rate of 8.4% and is expected
to reach 625 million by 2040.
Moreover, advancing technology in medical devices is adding fuel to the growth of the
market. Furthermore, increasing government support for the developing countries also
drives the market growth.
However, availability of expensive treatment and poor reimbursement policies in the
developing regions of the world are some of the factors, which may hamper the market
growth during the forecast period.
Segmentations
The Global Chronic Disease Management Market is segmented on the basis of service types,
by application, by deployment, and by end user.
On the basis of the service type, it is segmented into consulting service, implementation
service, educational services, and others.
On the basis of the application, it is segmented into asthma, cancer, cardiovascular,
diabetes, stroke, and others.
On the basis of the deployment, it is segmented into on premise, web based, and cloud
based.
On the basis of end user, it is segmented into provider and payer.
Key Players
TriZetto Corporation (U.S.), Phytel Inc (U.S.), Pegasystems Inc. (U.S.), AxisPoint Health
(U.S.), Wellcentive, Inc, Medecision, Inc (U.S.), i2i Systems, Inc (U.S.), HealthSmart
Holdings, Inc (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), ZeOmega Inc. (U.S.), Epic
Corporation Inc (U.S.), Harmony Information Systems, Inc. (U.S.), Infosys Limited (India)
Get Sample Copy at https://www.marketresearchfuture.com/sample_request/981 .
Regional Analysis
The Americas dominate the Global Chronic Disease Management Market owing to the rising
prevalence of chronic disease, unhealthy diets, high healthcare spending, and low physical
exercise. Furthermore increasing government support for research & development and the
concentration of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the global chronic disease management market owing
to the government support for research & development and availability of funds for
research. Although companies within this region are also involved in export to the
developing countries which leads the market of Europe.